Redefining clinical response in psoriasis: targeting the pathological basis of disease.
D006801:Humans; D011565:Psoriasis / Q000188:drug therapy* / Q000503:physiopathology*; D016032:Randomized Controlled Trials as Topic; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*
D011993:Recombinant Fusion Proteins